IL297791B2 - מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות - Google Patents
מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליותInfo
- Publication number
- IL297791B2 IL297791B2 IL297791A IL29779122A IL297791B2 IL 297791 B2 IL297791 B2 IL 297791B2 IL 297791 A IL297791 A IL 297791A IL 29779122 A IL29779122 A IL 29779122A IL 297791 B2 IL297791 B2 IL 297791B2
- Authority
- IL
- Israel
- Prior art keywords
- psychoactive
- alkaloid
- solvent
- weight
- psychoactive alkaloid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/078—Psilocybe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0215—Solid material in other stationary receptacles
- B01D11/0253—Fluidised bed of solid materials
- B01D11/0257—Fluidised bed of solid materials using mixing mechanisms, e.g. stirrers, jets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
- B01D11/0284—Multistage extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0292—Treatment of the solvent
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063040317P | 2020-06-17 | 2020-06-17 | |
| US202063046089P | 2020-06-30 | 2020-06-30 | |
| CA3088384A CA3088384C (en) | 2020-06-17 | 2020-07-29 | Extraction of psychoactive compounds from psilocybin fungus |
| CA3089455A CA3089455C (en) | 2020-06-17 | 2020-08-07 | Methanol-based extraction of psychoactive compounds from fungus |
| CA3097246A CA3097246C (en) | 2020-10-23 | 2020-10-23 | Process for obtaining a purified psychoactive alkaloid solution |
| CA3101765A CA3101765A1 (en) | 2020-12-04 | 2020-12-04 | Psychoactive alkaloid extraction and composition with controlled dephosphorylation |
| CA3103707A CA3103707C (en) | 2020-12-18 | 2020-12-18 | Standardized psychoactive alkaloid extract composition |
| PCT/CA2021/050813 WO2021253116A1 (en) | 2020-06-17 | 2021-06-14 | Compositions comprising psychoactive compounds from psychoactive organisms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IL297791A IL297791A (he) | 2022-12-01 |
| IL297791B1 IL297791B1 (he) | 2025-06-01 |
| IL297791B2 true IL297791B2 (he) | 2025-10-01 |
Family
ID=79022851
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299451A IL299451B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי אלקלואיד פסיכואקטיבי מפוספס בעיקר באמצעות אלקלי |
| IL298561A IL298561B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי על בסיס מתנול של תרכובות פסיכואקטיביות מפטריה |
| IL299453A IL299453B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מעוכבת |
| IL299449A IL299449B2 (he) | 2020-06-17 | 2021-06-14 | הרכב תמצית אלקלואיד פסיכואקטיבי סטנדרטי |
| IL299450A IL299450A (he) | 2020-06-17 | 2021-06-14 | מיצוי מבוקרת דה-פוספורילציה של אלקלואידים פסיכואקטיביים הניתנים לזרחני |
| IL297791A IL297791B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL299452A IL299452B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מבוקרת |
| IL305632A IL305632B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL299448A IL299448B2 (he) | 2020-06-17 | 2021-06-14 | תהליך להשגת תמיסת אלקלואיד פסיכואקטיבית מטוהרת |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299451A IL299451B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי אלקלואיד פסיכואקטיבי מפוספס בעיקר באמצעות אלקלי |
| IL298561A IL298561B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי על בסיס מתנול של תרכובות פסיכואקטיביות מפטריה |
| IL299453A IL299453B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מעוכבת |
| IL299449A IL299449B2 (he) | 2020-06-17 | 2021-06-14 | הרכב תמצית אלקלואיד פסיכואקטיבי סטנדרטי |
| IL299450A IL299450A (he) | 2020-06-17 | 2021-06-14 | מיצוי מבוקרת דה-פוספורילציה של אלקלואידים פסיכואקטיביים הניתנים לזרחני |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL299452A IL299452B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי והרכב אלקלואידים פסיכואקטיביים עם דה–פוספורילציה מבוקרת |
| IL305632A IL305632B2 (he) | 2020-06-17 | 2021-06-14 | מיצוי של תרכובות פסיכואקטיביות מפטריות פסיכדליות |
| IL299448A IL299448B2 (he) | 2020-06-17 | 2021-06-14 | תהליך להשגת תמיסת אלקלואיד פסיכואקטיבית מטוהרת |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US11331357B2 (he) |
| EP (1) | EP4161546A4 (he) |
| AU (7) | AU2021290454B2 (he) |
| BR (1) | BR112022025780A2 (he) |
| IL (9) | IL299451B2 (he) |
| MX (1) | MX2022016533A (he) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021067626A2 (en) | 2019-10-01 | 2021-04-08 | Intima Bioscience, Inc. | Genetic engineering of fungi to modulate tryptamine expression |
| CA3197443C (en) | 2020-12-28 | 2024-10-22 | Psilo Scientific Ltd. | METHODS FOR EXTRACTION OF PSYCHOACTIVE ALKALOIDS AND RELATED PREPARATION IN TRANSMUCOSAL FORMS |
| US20220370413A1 (en) | 2021-03-06 | 2022-11-24 | Mind Medicine, Inc. | Formulations of psilocin that have enhanced stability |
| CA3127180C (en) * | 2021-08-06 | 2024-03-05 | Psilo Scientific Ltd. | Pre-evaporation standardization of extracted psychoactive compounds |
| AU2022356260A1 (en) * | 2021-09-28 | 2024-04-11 | Joseph Girardi | Chilled juice extraction processes and products using psychedelic and functional mushrooms |
| CA3133547C (en) * | 2021-10-07 | 2024-07-02 | Psilo Scientific Ltd. | LIQUID-LIQUID EXTRACTION OF PURIFIED PSYCHOACTIVE ALKALOIDS |
| EP4457336A4 (en) | 2021-12-31 | 2026-01-14 | Empyrean Neuroscience Inc | ORGANISMS GENETICALLY MODIFIED TO PRODUCE PSYCHOTROPIC ALKALOIDS |
| WO2023225186A1 (en) * | 2022-05-18 | 2023-11-23 | Chemtor, Lp | Extraction of psilocybin and psilocin |
| GB202313750D0 (en) | 2023-09-08 | 2023-10-25 | Psyence Group Inc | A process for obtaining a purified psychoactive alkaloid |
| WO2025087962A1 (en) | 2023-10-23 | 2025-05-01 | Reconnect Labs Ag | Pharmaceutical formulations comprising 5-meo-dmt and their therapeutic uses |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101292727A (zh) * | 2008-05-30 | 2008-10-29 | 曹晋忠 | 菌类乙醇提取物的粉体制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE264023C (he) | ||||
| LU36879A1 (he) | 1958-02-21 | |||
| GB911946A (en) * | 1958-02-21 | 1962-12-05 | Sandoz Ltd | Psilocybin and psilocin and processes for their preparation |
| DD264023A1 (de) * | 1987-07-17 | 1989-01-18 | Akad Wissenschaften Ddr | Verfahren zur extraktion von indolalkaloiden aus pilzmaterial |
| US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| ATE407136T1 (de) | 2002-02-28 | 2008-09-15 | Mallinckrodt Inc | Verfahren und system zur trennung und aufreinigung wenigstens eines narkotischen alkaloids unter anwendung von präparativer umkehrphasenchromatographie |
| SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
| PL2063861T3 (pl) | 2006-09-15 | 2015-07-31 | Echo Pharmaceuticals Bv | Jednostka dawkowania do podawania podjęzykowego, podpoliczkowego lub doustnego nierozpuszczalnych w wodzie substancji aktywnych farmaceutycznie |
| BR112012024835A2 (pt) | 2010-03-30 | 2016-06-07 | Phosphagenics Ltd | adesivo de distribuição transdérmica |
| CN106573123B (zh) | 2014-06-30 | 2021-08-31 | Syqe医药有限公司 | 用于活性剂的肺部递送的方法、装置及系统 |
| US20180021326A1 (en) | 2016-07-23 | 2018-01-25 | Paul Edward Stamets | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin |
| NL2018190B1 (en) | 2017-01-18 | 2018-07-26 | Procare Beheer B V | Psilocybin or psilocin in combination with cannabinoid |
| WO2018148605A1 (en) | 2017-02-09 | 2018-08-16 | CaaMTech, LLC | Compositions and methods comprising a psilocybin derivative |
| US20190142851A1 (en) * | 2017-11-16 | 2019-05-16 | CaaMTech, LLC | Compositions comprising a psilocybin derivative and a cannabinoid |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| CN109528846A (zh) * | 2018-12-27 | 2019-03-29 | 贵州理工学院 | 一种植物中生物碱提取纯化的方法 |
| MX2021010753A (es) | 2019-03-07 | 2021-12-15 | Arbormentis LLC | Composiciones y métodos de uso que comprenden sustancias con acciones de plasticidad neural administradas a dosificaciones y formulaciones no psicodélicas/psicotomiméticas. |
| AU2020263392A1 (en) | 2019-04-26 | 2021-10-28 | The University Of North Carolina At Chapel Hill | Methods and compositions for dual glycan binding AAV2.5 vector |
| CA3097246C (en) | 2020-10-23 | 2023-03-28 | Psilo Scientific Ltd. | Process for obtaining a purified psychoactive alkaloid solution |
| WO2021003467A1 (en) | 2019-07-04 | 2021-01-07 | Sw Holdings, Inc. | Metered dosing compositions and methods of use of psychedelic compounds |
| WO2021007152A1 (en) | 2019-07-09 | 2021-01-14 | Refraction Ai, Inc. | Method and system for autonomous vehicle control |
| WO2021159213A1 (en) * | 2020-02-12 | 2021-08-19 | Neonmind Biosciences Inc. | Method for producing an extract of mushroom and mushroom extract made therefrom |
| CA3123908C (en) | 2020-06-17 | 2022-03-22 | Psilo Scientific Ltd. | Ethanol extraction of psychoactive compounds from psilocybin fungus |
| US11382942B2 (en) | 2020-06-17 | 2022-07-12 | Psilo Scientific Ltd. | Extraction of psychoactive compounds from psilocybin fungus |
| US20220054402A1 (en) | 2020-11-05 | 2022-02-24 | Richard C Kaufman | Compositions and methods for extracting, stabilizing, and manufacturing stable dosage forms of psilocin, psychedelic drugs, entheogens, and medicinal mushrooms as nano-dimensional drug delivery structures |
| US20220331292A1 (en) | 2021-04-16 | 2022-10-20 | Callitas Health Inc. | Compositions and methods for delivery of psilocin and prodrugs thereof |
| US12440472B2 (en) | 2021-06-16 | 2025-10-14 | Intelgenx Corp. | Stable tryptamine oral films |
-
2021
- 2021-06-14 IL IL299451A patent/IL299451B2/he unknown
- 2021-06-14 IL IL298561A patent/IL298561B2/he unknown
- 2021-06-14 IL IL299453A patent/IL299453B2/he unknown
- 2021-06-14 AU AU2021290454A patent/AU2021290454B2/en active Active
- 2021-06-14 IL IL299449A patent/IL299449B2/he unknown
- 2021-06-14 IL IL299450A patent/IL299450A/he unknown
- 2021-06-14 IL IL297791A patent/IL297791B2/he unknown
- 2021-06-14 MX MX2022016533A patent/MX2022016533A/es unknown
- 2021-06-14 IL IL299452A patent/IL299452B2/he unknown
- 2021-06-14 IL IL305632A patent/IL305632B2/he unknown
- 2021-06-14 BR BR112022025780A patent/BR112022025780A2/pt unknown
- 2021-06-14 IL IL299448A patent/IL299448B2/he unknown
- 2021-06-14 EP EP21825817.6A patent/EP4161546A4/en active Pending
- 2021-06-15 US US17/348,697 patent/US11331357B2/en active Active
- 2021-09-23 US US17/483,601 patent/US11298388B2/en active Active
-
2022
- 2022-03-17 US US17/697,798 patent/US11571450B2/en active Active
- 2022-03-23 US US17/702,701 patent/US11642385B2/en active Active
- 2022-12-19 AU AU2022291410A patent/AU2022291410B2/en active Active
- 2022-12-19 AU AU2022291414A patent/AU2022291414B2/en active Active
- 2022-12-19 AU AU2022291416A patent/AU2022291416B2/en active Active
- 2022-12-19 AU AU2022291411A patent/AU2022291411B2/en active Active
- 2022-12-19 AU AU2022291413A patent/AU2022291413B2/en active Active
-
2023
- 2023-12-19 AU AU2023285751A patent/AU2023285751B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101292727A (zh) * | 2008-05-30 | 2008-10-29 | 曹晋忠 | 菌类乙醇提取物的粉体制备方法 |
Non-Patent Citations (7)
| Title |
|---|
| AUSTRALIAN GOVERNMENT, DEPARTMENT OF HEALTH AND AGEING, GUIDANCE ON EQUIVALENCE OF HERBAL EXTRACTS IN COMPLEMENTARY MEDICINES., 28 February 2011 (2011-02-28) * |
| KUNLE, STANDARDIZATION OF HERBAL MEDICINES, 31 March 2012 (2012-03-31) * |
| KYSILKA, ROMAN, AND MILAN WURST., A NOVEL EXTRACTION PROCEDURE FOR PSILOCYBIN AND PSILOCIN DETERMINATION IN MUSHROOM SAMPLES., 31 December 1990 (1990-12-31) * |
| MOLDAVAN, M. G., ET AL., THE EFFECT OF PSILOCYBE CUBENSIS EXTRACT ON HIPPOCAMPAL NEURONS IN VITRO., 31 December 2001 (2001-12-31) * |
| WEBSITE DOCUMENT ENTITLED, MIKEY'S PSILLY ETHANOL EXTRACT, 24 March 2017 (2017-03-24) * |
| WEBSITE DOCUMENT ENTITLED, TRUFFLE MAGIC - SIMPLE METHOD OF PSILOCYBIN EXTRACTION, 24 June 2017 (2017-06-24) * |
| WURST, MILAN, ROMAN KYSILKA, AND TOMAS KOZA., ANALYSIS AND ISOLATION OF INDOLE ALKALOIDS OF FUNGI BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY., 31 December 1992 (1992-12-31) * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023285751B2 (en) | Powdered Composition Containing a Mushroom Extract Comprising a Psychoactive Alkaloid | |
| CA3173030C (en) | Predominantly phosphorylated psychoactive alkaloid extraction using alkali | |
| US11382942B2 (en) | Extraction of psychoactive compounds from psilocybin fungus | |
| US11510952B2 (en) | Ethanol extraction of psychoactive compounds from psilocybin fungus | |
| CA3137016C (en) | Psychoactive alkaloid extraction and composition with inhibited dephosphorylation |